BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11444869)

  • 1. Localization of N-terminal sequences in human AMP deaminase isoforms that influence contractile protein binding.
    Mahnke-Zizelman DK; Sabina RL
    Biochem Biophys Res Commun; 2001 Jul; 285(2):489-95. PubMed ID: 11444869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of functional domains in AMPD1 by mutational analysis.
    Gross M; Morisaki H; Morisaki T; Holmes EW
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1010-7. PubMed ID: 7802626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel aspects of tetramer assembly and N-terminal domain structure and function are revealed by recombinant expression of human AMP deaminase isoforms.
    Mahnke-Zizelman DK; Tullson PC; Sabina RL
    J Biol Chem; 1998 Dec; 273(52):35118-25. PubMed ID: 9857047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium activates erythrocyte AMP deaminase [isoform E (AMPD3)] through a protein-protein interaction between calmodulin and the N-terminal domain of the AMPD3 polypeptide.
    Mahnke DK; Sabina RL
    Biochemistry; 2005 Apr; 44(14):5551-9. PubMed ID: 15807549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of rat AMP deaminase 3 (isoform C) by development and skeletal muscle fibre type.
    Mahnke-Zizelman DK; D'cunha J; Wojnar JM; Brogley MA; Sabina RL
    Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):521-9. PubMed ID: 9291127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal extensions of the human AMPD2 polypeptide influence ATP regulation of isoform L.
    Haas AL; Sabina RL
    Biochem Biophys Res Commun; 2003 May; 305(2):421-7. PubMed ID: 12745092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent N-terminal regions in AMP deaminase and isoform-specific catalytic properties of the enzyme.
    Bausch-Jurken MT; Sabina RL
    Arch Biochem Biophys; 1995 Aug; 321(2):372-80. PubMed ID: 7646062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal sequence and distal histidine residues are responsible for pH-regulated cytoplasmic membrane binding of human AMP deaminase isoform E.
    Mahnke-Zizelman DK; Sabina RL
    J Biol Chem; 2002 Nov; 277(45):42654-62. PubMed ID: 12213808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning of human AMP deaminase isoform E cDNAs. Evidence for a third AMPD gene exhibiting alternatively spliced 5'-exons.
    Mahnke-Zizelman DK; Sabina RL
    J Biol Chem; 1992 Oct; 267(29):20866-77. PubMed ID: 1400401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subunit composition of AMPD varies in response to changes in AMPD1 and AMPD3 gene expression in skeletal muscle.
    Fortuin FD; Morisaki T; Holmes EW
    Proc Assoc Am Physicians; 1996 Jul; 108(4):329-33. PubMed ID: 8863347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the HPRG Component of Striated Muscle AMP Deaminase in the Stability and Cellular Behaviour of the Enzyme.
    Ronca F; Raggi A
    Biomolecules; 2018 Aug; 8(3):. PubMed ID: 30142952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards an understanding of the functional significance of N-terminal domain divergence in human AMP deaminase isoforms.
    Sabina RL; Mahnke-Zizelman DK
    Pharmacol Ther; 2000; 87(2-3):279-83. PubMed ID: 11008004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of AMP deaminase 1 binding to myosin heavy chain.
    Hisatome I; Morisaki T; Kamma H; Sugama T; Morisaki H; Ohtahara A; Holmes EW
    Am J Physiol; 1998 Sep; 275(3):C870-81. PubMed ID: 9730972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservation and expression of an alternative 3' exon of Runx2 encoding a novel proline-rich C-terminal domain.
    Terry A; Kilbey A; Vaillant F; Stewart M; Jenkins A; Cameron E; Neil JC
    Gene; 2004 Jul; 336(1):115-25. PubMed ID: 15225881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization and expression patterns of AMP deaminase1 (AMPD1) in porcine skeletal muscle.
    Wang L; Mo X; Xu Y; Zuo B; Lei M; Li F; Jiang S; Deng C; Xiong Y
    Comp Biochem Physiol B Biochem Mol Biol; 2008 Oct; 151(2):159-66. PubMed ID: 18638563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human AMP deaminase 2 (AMPD2) gene expression reveals alternative transcripts encoding variable N-terminal extensions of isoform L.
    Van den Bergh F; Sabina RL
    Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):401-10. PubMed ID: 8526848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proline-rich N-terminal sequence of calcineurin Abeta determines substrate binding.
    Kilka S; Erdmann F; Migdoll A; Fischer G; Weiwad M
    Biochemistry; 2009 Mar; 48(9):1900-10. PubMed ID: 19154138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Did myocilin evolve from two different primordial proteins?
    Mukhopadhyay A; Gupta A; Mukherjee S; Chaudhuri K; Ray K
    Mol Vis; 2002 Jul; 8():271-9. PubMed ID: 12142865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning of AMP deaminase isoform L. Sequence and bacterial expression of human AMPD2 cDNA.
    Bausch-Jurken MT; Mahnke-Zizelman DK; Morisaki T; Sabina RL
    J Biol Chem; 1992 Nov; 267(31):22407-13. PubMed ID: 1429593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anillin is a scaffold protein that links RhoA, actin, and myosin during cytokinesis.
    Piekny AJ; Glotzer M
    Curr Biol; 2008 Jan; 18(1):30-6. PubMed ID: 18158243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.